Comparative clinical trial of the progestins R-2323 and levonorgestrel administered by subdermal implants
- 1 August 1978
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 18 (2) , 151-162
- https://doi.org/10.1016/0010-7824(78)90090-2
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Clinical trial with subdermal implants of the progestin R-2323Contraception, 1977
- Contraceptive effectiveness of silastic: Implants containing the progestin R-2323Contraception, 1975
- Long-term contraception by steroid-releasing implants. II A preliminary report on long-term contraception by a single silastic implant containing norethindrone acetate (ENTA) in womenContraception, 1975
- Clinical evaluation of an oral progestin contraceptive, R-2323, 5mg, administered at weekly intervalsContraception, 1974
- Further studies on long-term contraception by subcutaneous silasticR∗ capsules containing megestrol acetateContraception, 1972
- Contraceptive action of megestrol acetate implants in womenContraception, 1971
- Longterm contraception by subcutaneous silasticR capsules containing megestrol acetateContraception, 1970
- Use of subcutaneous Silastic capsules for long-term steroid contraceptionAmerican Journal of Obstetrics and Gynecology, 1970
- Fertility control in women with a progestogen released in microquantities from subcutaneous capsulesAmerican Journal of Obstetrics and Gynecology, 1969
- Acceptability of long-term contraceptive steroid administration in humans by subcutaneous Silastic capsulesAmerican Journal of Obstetrics and Gynecology, 1969